Case report A 4-month-old Caucasian female presented with the develIn this case report, we evaluate the efficacy of allogeneic opmental milestones of a 1.-month-old infant and a history bone marrow transplantation (BMT) in a 7-month-old of ventriculoperitoneal shunt placement for hydrocephalus, female with the infantile form of Alexander's disease.
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megalencephaly and a generalized tonic-clonic seizure.
Based on research that describes Alexander's disease as
Neurological examination revealed head lag, absent deep a leukodystrophy which may result from an unidentified tendon reflexes, generalized proximal weakness, roving enzyme deficiency, we attempted marrow transplannystagmus and choreathetoid and ballistic movements of all tation to reverse or arrest the patient's neurological four extremities. A brain auditory evoked response (BAER) deterioration. Despite an initial return to her pretranswas consistent with nerve deafness. An electroencephaloplant neurological state, the patient's neurological gram (EEG) revealed generalized slow waves. A brain CT, status deteriorated. Marrow transplantation was not MRI (Figure 1 ) and biopsy ( Figure 2 ) were consistent effective in changing her prognosis with Alexander's with AD. disease. Keywords: Alexander's disease; leukodystrophy; alloBMT More than 30 patients with Alexander's disease (AD) have been reported since Alexander's description, in 1949, of an infant with megalencephaly, hydrocephalus and progressive neurological deterioration.
1 All have died secondary to the effects of neurodegeneration.
2 Some researchers have classified AD as a leukodystrophy, although an enzyme deficiency has not been documented. 3, 4 Since the etiology of the characteristic Rosenthal fiber (RF) accumulation in AD is not known, treatment is limited to supportive care alone. Patients with other leukodystrophies, particularly late infantile onset metachromatic leukodystrophies, have demonstrated slowing and sometimes arrest of neurological degeneration following BMT. [5] [6] [7] [8] Due to the degenerative and invariably fatal nature of AD and its similar clinical presentation to other leukodystrophies, we attempted to slow the neurological deterioration of an afflicted infant by allogeneic bone marrow transplantation (BMT) and report the clinical outcome. confirmed by EEG. A repeat brain CT showed no change in the low densities diffusely scattered throughout the white matter. A repeat BAER revealed no improvement. The patient was weaned off ventilatory support after 1 month and remained asymptomatic on room air. Her EEG showed no seizure activity nor generalized slow waves. She was discharged home 72 days following transplant on oral feeds, phenobarbital and diazepam.
Three months following BMT, she developed difficulty swallowing and progressive neurological deterioration. New onset spontaneous facial jerks, a right gaze nystagmus and bilateral exotropia were noted. Her extremities were now hypertonic with decerebrate posturing. A brain CT showed an extension of the diffuse white matter abnormality throughout the cerebrum (Figure 3 ), spreading to the brain stem (not shown). A nasojejunal feeding tube was placed because of her loss of swallow coordination. Her neurological function progressively worsened with episodes of apnea and bradycardia, and she died of respiratory failure 131 days following BMT. A post-mortem examination was not obtained.
Discussion
The rationale for treating our patient by BMT was based on the clinical and immunohistochemical similarities Due to the poor prognosis of AD and some evidence of benefit from marrow transplantation in other leukodystrophies, the infant was treated by a BMT at 7 months of age from her 4-year-old unaffected brother, completely matched at the major histocompatibility complex, on a protocol approved by the Institutional Review Board of the University of Chicago Hospitals. The preparative regimen consisted of busulfan (16 mg/kg total dose) on days −9 to −6 and cyclophosphamide (200 mg/kg total dose) on days −5 to −2. Graft-versus-host disease prophylaxis consisted of methotrexate on days +1, +3, +6 and +11 and then weekly until day +46.
Post-transplant management included transfusions with irradiated washed packed red blood cells and platelets. Treatment with mezlocillin, gentamicin, vancomycin and amphotericin was administered for 2 weeks for fever and neutropenia. Engraftment was documented by day +15 (absolute neutrophil count greater than 250/mm 3 for 2 consecutive days) and the patient became platelet transfusionindependent on day +17. She was discharged 22 days after transplant on oral feeds, dilantin and phenobarbital.
She was readmitted 31 days after transplant with Pneu- support. While intubated, she developed status epilepticus between AD and other leukodystrophies, particularly metamarrow engraftment by our patient's absolute neutrophil counts greater than 250/mm 3 and transfusion independence chromatic leukodystrophy (MLD), which has been successwhich were later followed by a 1 month period of neurofully treated by BMT.
5-8 Our patient, who presented with logic stabilization. (Engraftment of the donor's bone marthe infantile form of AD characteristically had a life expectrow was not confirmed by chromosome or restriction fragancy of between 2 months and 7 years, with the primary ment length polymorphism analysis.) Since quantifiable, cause of death relating to progressive neurologic degenermetabolic markers for AD have not been discovered, it is ation. 1,9 Her brain CTs and MRI revealed progressive difpossible that therapeutic levels of a deficient enzyme were fuse demyelination which were characteristic of AD and not sufficiently restored within the 4 months of our patient's other forms of leukodystrophy. 10 life after BMT. Finally, unlike late infantile onset MLD and Microscopic analysis of her brain biopsy revealed an other leukodystrophies, infantile AD may not result from a accumulation of intracytoplasmic RFs which was characterdeficient enzyme that could be replaced by BMT. This istic for AD. 3 It is hypothesized that RFs may accumulate patient's progressive neurodegeneration demonstrated that in AD due to dysfunctional astrocyte metabolism.
11,12
BMT did not alter the usual course of infantile AD. Whether the massive increase of RFs is secondary to an increased synthesis or reduced degradation of proteins is currently unknown. 3, 9, 11 Such an abnormality in the proteolytic system of astrocytes is believed to cause the demyelinAcknowledgements ation seen in patients with AD. 4, 9 The progressive neurodegeneration due to RF deposition and myelin loss suggest We assessed our patient's progress after BMT by correl- We suggest several possible reasons for the failure of 
